DDB treatment of patients with chronic hepatitis
Roman Huber, Birgit Hockenjos, Hubert E. Blum – 27 May 2004 – We report 13 patients (10 with chronic hepatitis C, 1 with chronic hepatitis B, 2 with nonalcoholic steatohepatitis) with persistently elevated alanine aminotransferase (ALT) levels who were treated with dimethyl‐4,4′‐dimethoxy‐5,6,5′,6‐dimethylenedioxybiphenyl‐2,2′ dicarboxylate (DDB). ALT rapidly normalized in 12/13 patients and remained normal during treatment. Unlike ALT levels, aspartate aminotransferase, gamma‐glutamyl transferase and glutamate dehydrogenase levels were not affected.